Janney Montgomery Scott LLC Abiomed Inc Transaction History

Janney Montgomery Scott LLC

$42.2 Billion
Q3 2025

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Oct 25, 2022	BUY	$242.49 - $301.46 $500,741 - $622,514	2,065 New	2,065 $507,000
Q1 2021 Apr 27, 2021	SELL	$285.92 - $355.13 $1.33 Million - $1.65 Million	-4,656 Closed	0 $0
Q4 2020 Jan 25, 2021	BUY	$251.88 - $324.2 $70,526 - $90,776	280 Added 6.4%	4,656 $1.51 Million
Q3 2020 Nov 06, 2020	SELL	$255.22 - $317.0 $131,948 - $163,889	-517 Reduced 10.57%	4,376 $1.21 Million
Q2 2020 Jul 23, 2020	SELL	$141.4 - $257.09 $25,452 - $46,276	-180 Reduced 3.55%	4,893 $1.18 Million

Q1 2020 Apr 30, 2020	SELL	$130.51 - $196.01 $294,691 - $442,590	-2,258 Reduced 30.8%	5,073 $736,000
Q4 2019 Jan 21, 2020	BUY	$159.31 - $223.54 $469,327 - $658,548	2,946 Added 67.18%	7,331 $1.25 Million
Q3 2019 Oct 29, 2019	BUY	$175.89 - $279.23 $589,759 - $936,258	3,353 Added 324.9%	4,385 $780,000
Q2 2019 Jul 29, 2019	SELL	$250.96 - $284.94 $88,086 - $100,013	-351 Reduced 25.38%	1,032 $269,000
Q1 2019 Apr 30, 2019	SELL	$276.39 - $362.25 $99,500 - $130,410	-360 Reduced 20.65%	1,383 $395,000
Q4 2018 Feb 01, 2019	SELL	$281.08 - $444.25 $44,410 - $70,191	-158 Reduced 8.31%	1,743 $567,000
Q3 2018 Nov 05, 2018	SELL	$354.53 - $449.75 $48,925 - $62,065	-138 Reduced 6.77%	1,901 $855,000
Q2 2018 Jul 24, 2018	BUY	$278.07 - $446.21 $79,528 - $127,616	286 Added 16.31%	2,039 $834,000
Q1 2018 Apr 19, 2018	SELL	$192.49 - $295.85 $6,352 - $9,763	-33 Reduced 1.85%	1,753 $510,000
Q4 2017 Feb 14, 2018	SELL	$168.78 - $199.74 $188,527 - $223,109	-1,117 Reduced 38.48%	1,786 $335,000
Q3 2017 Nov 15, 2017	BUY	$145.39 - $168.6 $422,067 - $489,445	2,903	2,903 $489,000

Others Institutions Holding ABMD

# of Institutions

Shares Held

137K

Call Options Held

Put Options Held

View Full List

About ABIOMED INC

Ticker ABMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 45,460,900
Description
Abiomed, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It also provides a continuum of care to heart failure patients. The company offers Impella 2.5, a percutaneous micro heart pump with integrated motor and sensors; and Impella CP, a device for use by inte...

More about ABMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Janney Montgomery Scott LLC, based on Form 13F filings with the SEC.

News

Stay updated on Janney Montgomery Scott LLC with notifications on news.

Account